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Abstract
A neuroprotective role for Ca2+-binding proteins in neurodegenerative conditions ranging from ischemia to Alzheimer’s disease has been
suggested in several studies. A key phenomenon in neurodegeneration is the Ca2+-mediated excitotoxicity brought about by the
neurotransmitter glutamate. To evaluate the relative ability to resist excitotoxicity of neurons containing the slow-onset Ca2+-binding protein
parvalbumin (PV), we injected the glutamate agonist ibotenic acid (IBO) into the striatum of adult mice ectopically expressing PV in neurons.
Striatal ibotenic acid injection results in local nerve cell loss and reactive astrogliosis. Light microscopic evaluation, carried out after a delay
of 2 and 4 weeks, reveals an enlarged and accelerated neurodegenerative process in mice ectopically expressing neuronal PV. Thus, PV is not
neuroprotective, it rather enhances nerve cell death. This result implicates that the increase in cytosolic Ca2+-buffering capacity in the
transgenic mice impairs other systems involved in Ca2+ sequestration. In addition, ultrastructural morphometric analysis shows that in
neurons the mitochondrial volume is reduced in mice ectopically expressing neuronal PV. This is paralleled by a reduction in the amount of
the mitochondrial marker enzyme cytochrome c oxidase subunit I (COXI). We conclude that alterations in the Ca2+ homeostasis present in
mice ectopically expressing neuronal PV are more deleterious under excitotoxic stress and largely outweigh the potential benefits of an
increased Ca2+-buffering capacity resulting from PV.
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Introduction
Excitatory amino acid neurotransmitters play an impor-
tant role in acute and chronic diseases in the CNS, including
stroke, Huntington’s, Alzheimer’s and Parkinson’s disease
(for reviews, see DiFiglia, 1990; Dirnagl et al., 1999;
Hossmann, 1994; Lipton and Rosenberg, 1994). The neu-
rotoxicity of these substances can be considered as an
exaggeration of the physiological action of glutamate as a
neurotransmitter, that is, binding to its postsynaptic recep-
tors. The result is an overstimulation of N-methyl-D-aspar-
tate (NMDA), alpha-amino-3-hydroxy-5-methyl-4-isoxazo-
lepropionic acid (AMPA) and kainate receptors (Weiss and
Sensi, 2000), with consequent influx of Na+ and Ca2+ ions
through the channels gated by these receptors. Excessive
Ca2+ influx is mediated directly and predominantely by
NMDA receptors, which gate channels that are highly
permeable to Ca2+, but is also triggered secondarily by
Na+ influx through AMPA and kainate receptors, as well
as via activation of voltage-gated Ca2+ channels and reverse
operation of the Na+/Ca2+ exchanger. Further, the gluta-
mate-mediated activation of metabotropic receptors induces
release of Ca2+ from intracellular stores. Together, this
results in elevated intracellular Ca2+ concentrations (Choi,
1988; 1995) with serious consequences such as necrosis and
apoptosis (Lee et al., 1999). Stimulation of catabolic
enzymes and induction of Ca2+ sequestration in the mito-
chondrial matrix, which leads to a collapse of mitochondrial
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membrane potential, have been described (Schinder et al.,
1996). Blockade of glutamate receptors prevents most of the
Ca2+ influx and neuronal cell death induced by glutamate
exposure (Simon et al., 1984; Turski et al., 1998).
Parvalbumin (PV) is a cytosolic Ca2+ buffer expressed in
GABAergic (g-aminobutyrate) neurons in the cerebral and
cerebellar cortex and is present in numerous nuclei of the
brain (Andressen et al., 1993; Hontanilla et al., 1998). In
rodent striatum, PV-containing neurons are rare and occur
mainly in the peripheral regions of striosomes where they
participate in linking the two striatal compartments (Kita et
al., 1990).
The correlation between PV and excitotoxic cell death is
still unclear. On the one hand, a neuroprotective role for PV
has been described in hippocampal interneurons surviving
delayed ischemic cell death after a transient bilateral occlu-
sion of the carotid arteries (Nitsch et al., 1989). PV-con-
taining neurons also exhibit a higher survival rate in the
human epileptic hippocampus (Sloviter et al., 1991), and
recently, a protective effect of PV on excitotoxic motor
neuron death has been observed (Van Den Bosch et al.,
2002). On the other hand, PV-containing neurons are
supposed to be selectively vulnerable in Alzheimer’s disease
(Solodkin et al., 1996) and not to be protected in some
forms of epilepsy (Bouilleret et al., 2000). In an in vitro
model, a HSV-1 vector-driven expression of PV in cultured
cortical neurons resulted in an enhancement of NMDA
neurotoxicity (Hartley et al., 1996).
To determine the role of PV in excitotoxicity, we injected
ibotenic acid (IBO) in the striatum of mice ectopically
expressing neuronal PV. IBO is an agonist of glutamate
(Zorumski et al., 1989). It induces neurodegeneration by
activation of the NMDA receptors (Marret et al., 1996) and
by coactivation of the metabotropic glutamate receptors,
mediating the release of Ca2+ from intracellular stores. This
results in well-demarcated lesions (Inglis and Semba, 1997),
which can be easily compared in wildtype mice (WT) and
transgenic mice. We show here that neurons expressing PV
ectopically are more vulnerable against excitotoxic stress.
Materials and methods
Mice
Transgenic mice with a C57BL/6J background, 20–34 g
in weight (n = 18), ectopically expressing PV under the
control of the pan-neuronal Thy-1 promoter were used (Van
Den Bosch et al., 2002). In the CNS, the Thy-1 promoter
driving the expression of PV has been previously shown to
be active in neurons (Andra et al., 1996; Caroni, 1997;
Wisden et al., 2002), but expression levels can vary con-
siderably among different neuron types. Mice expressing the
highest level of PV were selected for this study. As control
strain, C57BL/6J mice, 20–31 g in weight (n = 18) were
used. At the day of injection, the age of the mice ranged
from 95 to 296 days. No sex- or age-related variations
concerning the following investigations have been observed.
For quantitative analysis of mitochondria, 8 transgenic mice
and 10 WT were used, in addition. All animal experiments
were performed with permission of the local animal care
committee and according to the present Swiss law.
Determination of genotype
Detection of transgenic mice was carried out by PCR on
genomic mouse tail DNA as described previously (Castillo
et al., 1995). Briefly, rat-specific PV cDNA primers (OL1
5V-TCCAGATGGTGG-GCCTGAAGAAAAAGAGTG-3V
and OL2, 5V-GTCCCCGTCCTTGTCTCCAGCAGCC-
ATC-3V as the 5V and 3V primers) and, as a template, 1 Ag
of genomic DNA were used. A PCR amplicon of 194 bp
was produced. In addition, PV immunohistochemistry was
carried out to confirm the results obtained by PCR.
Surgical procedure
Under combined anesthesia with ketaminum (KetaminR,
0.1 g/kg ip), xylazinum (NarcoxylR, 0.02 g/kg ip) and
atropin (Atropin, 0.05 mg/kg ip), mice were placed in a
stereotaxic apparatus. Ibotenic acid (IBO; Sigma, 0.4 Ag in
0.4 Al buffered saline) was injected with a glass capillary
glued onto a Hamilton microsyringe at the coordinates AP +
4.8 mm, L 2.1 mm and V 2.5 mm above ear zero plane
according to the atlas of Franklin and Paxinos (1997).
Injection time was 10 min, and further 10–15 min elapsed
before the needle was withdrawn and the wound closed.
After the effects of anesthesia had subsided, most of the
mice showed a marked tendency to rotate to the side
contralateral to the injection, some of them rotated ipsilat-
eral, a behavior which correlates with the exact localization
of the excitotoxin injection. Sham animals (two each, of WT
and of the transgenic ones) were injected with the same
amount of 0.9% NaCl and showed no rotation behavior.
Tissue preparation
After a recovery period of 2 weeks (9 transgenic, 6 WT)
and 4 weeks (7 transgenic, 10 WT), the animals were deeply
anesthetized with pentobarbital (VetanarcolR, 0.04 g/kg ip)
and transcardially perfused first with 4% paraformaldehyde
and 0.2% glutaraldehyde in 0.1 M phosphate buffer, pH 7.4,
followed by the same fixative without glutaraldehyde. The
dissected brains were immersed in fixative overnight.
Histology and immunohistochemistry
Serial sagittal 40-Am sections were cut with a vibratome
and collected in cold Tris phosphate buffer (TBS, 0.05 M).
To measure the extent of nerve cell death and the position of
the needle, every fifth section was mounted on glycerin-
coated slides and stained with 0.5% cresyl violet.
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To evaluate PV immunoreactivity and astrocytic reac-
tion, immunohistochemistry on every fifth section was
performed as already described (Nitsch et al., 1995). In
brief, free-floating sections were treated with 1% NaBH4 for
10 min, washed thoroughly and solubilized with 0.4%
Triton X-100 in 0.05 M Tris-buffered saline (TBS) for 90
min. Nonspecific binding was blocked with normal serum
(horse or goat serum) for 2 h, then sections were incubated
Fig. 1. Parvalbumin (PV) immunohistochemistry shown in parasagittal brain sections of a wildtype (left panel) and a mouse ectopically expressing PV in its
neurons (right panel). (a) In wildtype, PV expression is pronounced in interneurons, mainly in the neocortex (C), hippocampus (H), in neurons of the globus
pallidus (P) and the thalamus (T), while in the striatum (S), only few PV-containing interneurons are observable. (b) An increased homogenous PV
immunoreactivity throughout the gray matter of the whole brain is characteristic for the transgenic mouse. (c) Staining is absent in the wildtype striatum (S)
except for a few clearly marked interneurons (arrows), in contrast to the globus pallidus (P) with its many PV-positive neurons. (d) The same area in the
transgenic mouse shows a dense PV immunoreactivity in the striatal neuropil, only omitting the fiber tracts of the internal capsule. Although the staining in
globus pallidus tends to appear weaker than in wildtype (c), PVamount in pallidal neurons is probably similar in both strains, suggesting that the contrast to the
neighboring striatum is responsible for this erroneous perception. (e) Single PV immunoreactive interneurons of the striatum with their locally branching
dendrites. (f) Dense PV immunoreactivity in mice ectopically expressing PV in their neurons blurs the dendritic arborization of the PV-containing interneurons.
Perikarya of PV-immunoreactive interneurons exhibit a stronger signal than perikarya in which PV has been up-regulated by the transgene. Scale bar for a, b =
1 mm, c– f = 100 Am.
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with antibodies against PV (monoclonal PV235, 1:20,000;
Swant, Bellinzona, Switzerland) or glial fibrillary acidic
protein (GFAP, 1:1000; Sigma) for 48 h at room tempera-
ture. Biotinylated horse anti-mouse (1:200; Vector) or goat
anti-rabbit IgG (1:100; Antibodies Inc.), and the avidin–
biotin complex (Vector) were applied for 90 min each.
Immunoreaction was visualized with 0.05% diaminobenzi-
dine and 0.1% H2O2 in TBS.
All sections were mounted in series from lateral to
medial on coated slides, dehydrated in graded ethanol,
cleared with xylol and coverslipped in Eukitt (Kindler,
Freiburg, Germany).
Fig. 2. (a–d) Ibotenate-induced lesions in wildtype (left panel) and mice ectopically expressing PV in their neurons (right panel) visualized in cresyl-stained
sections, obtained after 2 weeks (a, b) and after 4 weeks (c, d). A small necrotic center (Ne), where the capillary tip has been positioned and where all tissue
elements are destroyed, is surrounded by a large zone of nerve cell loss (arrowheads). Most of the affected area is striatal tissue (S), but also parts of the globus
pallidus (P) are affected. Cortex (C). (e– f) Ibotenate-induced lesions visualized in GFAP immunohistochemistry after 2 (e, f) and 4 weeks survival time (g, h).
Note the larger extent of astrocytosis compared to neuronal cell loss in general, but also the pronounced involvement of cortical tissue (Cl) in transgenic mice
(f, h) and the strongly reduced extent of GFAP immunoreactivity in transgenic mice after 4 weeks survival time compared to the extent of activated GFAP after
2 weeks (f, h). Scale bar = 500 Am.
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Quantitative Western blot analysis
A membrane protein fraction was prepared by homog-
enization of forebrain tissue in homogenization buffer [10
mM Tris–HCl, 1 mM EDTA, pH 7.4, containing one
tablet of protease inhibitor cocktail (Roche; cat. nr.
1873580) per 10 ml of buffer] using a Polytron homog-
enizer. Membranes were sedimented by centrifugation at
30,000  g for 30 min, resuspended in homogenization
buffer, once more sedimented under the same conditions
and then resuspended in 1% SDS. Membrane proteins
were solubilized by addition of 10% SDS to a final
concentration of 5.5%. Protein concentration was deter-
mined by the protein Dc assay kit (Bio-Rad). Proteins (50
Ag) were separated by polyacrylamide gel electrophoresis
(SDS-PAGE) and transferred on nitrocellulose membranes
using a semidry transfer protocol. The membranes were
assayed for even protein load and possible transfer
artifacts by staining with Ponceau red solution. After
blocking with 10% solution of nonfat milk in TBS-T
buffer (TBS with addition of 0.05% of Tween 20),
membranes were incubated with primary antibodies
against cytochrome c oxidase subunit I (COXI; 0.5 Ag/
ml, ID6-E1-A8, IgG2a,n, Molecular Probes, Leiden, Neth-
erlands, cat. A-6403) using a modified protocol according
to Capaldi et al. (1995). Antibodies were diluted in TBS-
T solution containing 1% of protease-free bovine serum
albumin. Incubation of membranes with primary antibod-
ies was followed by extensive washing in TBS-T and
subsequently by incubation of membranes with appropri-
ate secondary biotinylated antibodies (1:10,000; Vector).
After extensive washing, membranes were incubated with
avidin–biotin-conjugated peroxidase (Vector) solution in
TBS-T, washed again and the bands corresponding to
COXI were visualized. The subunit I-specific band of
approximately 60 kDa (theoretical Mr: 57 kDa) was used
for the quantitative analysis using the Molecular Imager
hardware and software from the same manufacturer.
Exposition on the phosphoimager screen was 15 min.
Linearity of the COXI signal was checked by analyzing
different amounts of muscle membrane proteins and
different exposition times.
Morphometric analysis of neuronal mitochondria
Untreated striatal tissue from unstained vibratome sec-
tions were processed for transmission electron microscopy.
The sections were incubated with 0.1% osmium tetroxide
(OsO4; Serva), dehydrated until 70% ethanol, incubated
with 1% uranyl acetate (Merck, Darmstadt, Germany) in
70% ethanol, dehydrated until 100% ethanol, transferred in
propylene oxide (Merck) and embedded in a plastic resin
(Epon; Serva). Ultrathin sections were analyzed under the
electron microscope (Philips CM 10 Digital). Eight neu-
rons were randomly selected in one grid per animal, and
three digital micrographs (analySISR) per neuron were
Fig. 3. (a) Size of the neuron-depleted area in wildtype mice and in mice ectopically expressing PV in their neurons: transgenic mice show after 2 weeks (3.46
versus 2.38 mm2; P = 0.003) as well as after 4 weeks (3.00 versus 2.16 mm2; P = 0.003) a larger extent of the neuron-depleted area as compared to wildtype. (b)
Extent of astrocytosis in wildtype mice and in mice ectopically expressing PV in their neurons: astrocytosis is more pronounced in transgenic mice than in
wildtype mice after 2 weeks (3.89 versus 2.83 mm2; P = 0.001), this difference is no longer significant after 4 weeks (2.94 versus 2.58 mm2; P = 0.25). The
reduction in the extent of GFAP immunoreactivity from 2 to 4 weeks is significant in the transgenic strain (P = 0.02) but not in wildtype mice (P = 0.23). (a, b)
GFAP-stained areas tend to be larger than the corresponding neuron-depleted areas after 2 weeks in both mouse strains (P = 0.11 in transgenic, P = 0.16 in
wildtype), this tendency has disappeared in transgenic mice after 4 weeks (P = 0.88), but has become significant in wildtype (P = 0.03).
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taken out of the perikaryon at positions 12, 4 and 8 o’clock
in direct contact to the nucleus at a primary magnification
of 11,000.
Data analysis
For histological measurements, the section with the
largest lesion, often exhibiting the needle tract, was select-
ed in cresyl and GFAP staining (laterality = 2.00–2.20
mm), and size of the striatum, the central necrosis, the
neuron-depleted area and the extent of astrocytosis were
analyzed with Leica Image Scale system. For analysis of
the Western blot, the bands corresponding to COXI were
quantified by the Molecular Imager (Bio-Rad) using the
ECL chemoluminescence method (Pierce). The area of
neurons occupied by mitochondria was determined with
Image-ProR software.
Data were calculated using the mean and SEM. Signif-
icance was determined with Student’s t test. All measure-
ments and analyses were performed without knowing the
genotype of the analyzed specimen. The identity of the
samples was only revealed after completion of the analyses.
Results
Phenotype of transgenic mice is distinguishable from WT
with respect to PV expression
Transgenic mice were found to have no apparent pheno-
type when kept under standard housing conditions. In PV
immunohistochemistry, there was an increased PV immu-
noreactivity throughout the brain since all neurons express
PV. Nevertheless, the characteristic pattern of PV distribu-
Fig. 4. Electron micrographs of a wildtype striatal neuron (left panel) and a neuron ectopically expressing PV (right panel) revealed more fractional
mitochondrial area in wildtype neurons. Measurements were performed in digital micrographs taken at a primary magnification of  11,000 in the perikaryal
field directly adjacent to the nucleus at 12, 4, and 8 o’clock irrespective of the presence or absence of mitochondria (small figures from top to bottom).
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tion was discernible: the expression level in neurons nor-
mally expressing PV (Celio, 1990) was still obviously
higher than in all other neurons, for example, interneurons
in the neocortex, the hippocampus (Nitsch et al., 1995), the
reticulothalamic nucleus (compare Figs. 1a, b) and the
cerebellum (not shown). In wildtype striatum with its low
number of PV-containing interneurons (Figs. 1c, e), staining
is virtually absent. In contrast, in striatum of transgenic
mice, presence of PV in all striatal neurons results in a
homogenous staining that blurs the dendritic arborizations
of the PV-containing interneurons (Figs. 1d, f).
Injection of ibotenic acid in the mouse striatum provokes a
central necrosis surrounded by a drop-shaped
neuron-depleted zone
The histological aspect of the IBO-induced lesion was
similar to previous studies (Schwarcz et al., 1979). In both
WT and mice ectopically expressing neuronal PV, striatal
injection of IBO provoked a globular or drop-shaped neuron-
depleted zone (Figs. 2a–d) and a zone of activated glia (Figs.
2e–h), surrounding a small globular-shaped central necrosis.
As a typical feature of IBO, the border of the neuron-
depleted area to healthy tissue was abrupt. Since the lesion
was often about as large as the whole striatum, some animals
were injured also in flanking cortical areas (Figs. 2b, d). In
sham animals, the needle tract was identifiable in all stain-
ings, but no other alteration of tissue (necrosis and/or neuron
depletion) was detectable (not shown).
Vulnerability of neurons ectopically expressing PV to
excitotoxic stress is enhanced
Quantitative analyses revealed that sizes of necrotic zones
between transgenic mice andWT did not differ (after 2 weeks
0.32 versus 0.15 mm2; P = 0.11, after 4 weeks 0.23 versus
0.20 mm2; P = 0.75). However, the neuron-depleted area in
mice ectopically expressing neuronal PV was larger than in
WT, 45% after 2 weeks and 39% after 4 weeks (Fig. 3a). The
size of the striatum shrunk in both strains from 2 to 4 weeks
by around 25% (P < 0.001, data not shown). As there is a
concentration gradient of IBO from the center of the
injection to the periphery, it can be concluded that neurons
ectopically expressing PV have a lower threshold level of
being damaged through excitotoxic stress.
Astrocytic reaction to excitotoxic stress is enhanced in mice
ectopically expressing neuronal PV
Astrocytic reaction to excitotoxic stress was evaluated by
GFAP immunoreactivity. This astroglial marker was up-
regulated near and in the neuron-depleted zone in both
mouse strains.
After 2 weeks, astrocytosis was 37% more widespread in
transgenic mice than in WT. Both mouse strains showed a
pronounced GFAP immunoreactivity in the outer border of
the neuron-depleted area reproducing the inward migration
of activated astrocytes from the periphery to the center of a
lesion over time (Dusart et al., 1991). The necrotic core was
devoid of reactive astrocytes (Figs. 2e–f).
After 4 weeks, the difference in extent of astrocytosis
between the two strains was no longer significant. GFAP
was equally distributed in the whole lesioned area, a partial
astroglial reinvasion of the central necrosis was observed in
a few cases (Figs. 2g–h). The reduction in extent of GFAP
immunoreactivity from 2 to 4 weeks was significant in mice
ectopically expressing neuronal PV but not in WT (Fig. 3b).
Fractional mitochondrial area of neurons ectopically
expressing PV is decreased
To compare the mitochondrial fraction of neurons ectop-
ically expressing PV with wildtype neurons, morphometric
analyses were carried out on electron microscopical sections
obtained from striatal neurons of untreated mice ectopically
expressing neuronal PV and untreated WT (Fig. 4). The
fractional mitochondrial area in perikarya of Thy-PV neu-
rons was massively reduced to nearly half compared to
values obtained for WT (16.71%, n = 4 versus 30.28%, n =
6; P = 0.0003).
Semiquantitative Western blot analysis of the mitochon-
drial protein COXI (Chen et al., 2001) was done in the
forebrain of mice and confirmed our morphometric mito-
chondria data. In samples of mice ectopically expressing
neuronal PV, the signal for COXI was weaker as compared
to that from WT (Fig. 5). Quantitative analysis of the
Western blot signals with the help of a phosphoimager
system showed a down-regulation of COXI by approxi-
mately 15% in the forebrain of transgenic mice (3.39 versus
4.04 arbitrary units, P < 0.005).
Discussion
In this study, we demonstrate that the mouse striatum and
adjacent cortex when ectopically expressing neuronal PVare
Fig. 5. Semiquantitative Western blot analysis of cytochrome c oxidase
subunit I in forebrain tissue revealed a weaker signal in samples of mice
ectopically expressing PV in their neurons (Thy-PV) compared to samples
from wildtype (WT) mice.
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more susceptible to IBO-induced excitotoxic injury. Further,
ectopically expressed neuronal PV accelerates the progres-
sion of the pathologic process.
Excitotoxic cell death within the central nervous system
induced by prolonged exposure to glutamate or glutamate
agonists (e.g. IBO, NMDA) is closely linked to an exag-
gerated influx of Ca2+ in neurons often described as ‘‘Ca2+
overload’’. This type of cell death is regularly studied as a
model of stroke mimicking the situation in ischemic brain,
where glutamate accumulation to high concentrations is
observed. The changes in the temporal pattern of the
intracellular Ca2+ concentration [Ca2+]i following glutamate
application are remarkably constant in most models: an
initial transient [Ca2+]i rise, staying at a plateau for extended
periods or with an incomplete recovery towards baseline
(e.g. D’Orlando et al., 2001). For a long time, the hypothesis
has been that addition of intracellular Ca2+ buffers such as
PV or calbindin D-28k (CB) may confer a neuroprotective
role in these models (Heizmann and Braun, 1992). While
initial investigations mainly reported on a correlation of
preferentially surviving neuronal populations and specific
Ca2+ buffers, as discussed in D’Orlando et al. (2001, 2002),
more recent studies have directly addressed the question of
neurodegeneration. Systems in vitro or in vivo, where
expression levels of CaBPs were directly manipulated,
include transfected cell lines or transgenic animals with
either deletions of CaBP genes or ectopically expressing
CaBPs (reviewed in Schwaller et al., 2002).
Results on a neuroprotective role of PV are extremely
heterogenous and examples discussed here are limited to the
effects of PV on glutamate- or glutamate agonist-induced
excitotoxicity and in amyotrophic lateral sclerosis (ALS).
For the latter studies, two groups made use of transgenic
mice either ectopically expressing PV under the control of
the rat calmodulin II (CaMII) (Beers et al., 2001) or the
Thy-1 promoter (Van Den Bosch et al., 2002) to assess
whether increasing the Ca2+-buffering capacity of moto-
neurons may protect them from excitotoxic cell death.
Motoneurons are considered to be particularly susceptible
to Ca2+-mediated glutamate toxicity due to the lack of a
substantial amount of any CaBP (Shaw and Eggett, 2000),
in line with their relatively low endogenous Ca2+-buffering
capacity compared to other neuronal populations (Lips and
Keller, 1998; Palecek et al., 1999). In CaMII-PV transgenic
mice, PV expressing motoneurons were better suited to
attenuate ALS IgG-mediated increases in total calcium
within motor axon terminals of interosseus muscles (Beers
et al., 2001). When these mice were bred with transgenic
mice expressing a mutant form of SOD1 (mSOD1), a model
of familial ALS, motoneuron loss was decreased and the
disease onset was delayed compared to mSOD1 mice.
Kainate-induced toxicity was also better tolerated in moto-
neuron cultures in vitro derived from Thy-PV mice
evidenced by the increased number of surviving motoneur-
ons (Van Den Bosch et al., 2002). Dekkers et al. (in press)
have demonstrated that in the same mouse strain (Thy-PV),
motoneuron survival in vivo following nerve injury (crush-
ing of the sciatic nerve) also with the likely involvement of
excitotoxic effects of glutamate was significantly increased
compared to control wildtype mice. All the above results
demonstrate that ectopic expression of PV in motoneurons
has a neuroprotective effect.
On the other hand, the extent of kainate-induced excito-
toxicity (a model of mesial temporal lobe epilepsy) was not
influenced by the presence of PV, CB or calretinin (CR): the
extent of neuronal damage was similar in animals deficient
for one or two of these proteins (Bouilleret et al., 2000). In
cultures of cortical neurons using a herpes simplex virus-1
vector system containing the PV cDNA, NMDA-induced
excitotoxicity was even increased, not decreased (Hartley et
al., 1996). In our experiments with Thy-PV mice, we found
a similar yet unexpected situation, namely, the excitotoxic
damage induced by IBO was aggravated in mice ectopically
expressing PV in striatal neurons. How can we reconcile
such apparently contradicting results in different neuronal
populations in the same mouse model?
Three possible mechanisms might be involved: (a) sys-
tems implicated in regulating [Ca2+]i in a given neuron type
(Ca2+ channels or pumps, organelles involved in Ca2+
homeostasis); (b) ‘‘compensation’’ or ‘‘remodeling’’ mech-
anisms induced by either removal or ectopic expression of a
Ca2+ buffer and (c) the biophysical parameters of the Ca2+
buffer (Ca2+ affinity and metal-binding kinetics, mobility),
but this does not need to be discussed in great detail since
the expression of PV in Thy-PV mice is increased in both
cases, in motoneurons and striatal neurons.
First, studies on the systems regulating Ca2+ homeostasis
were carried out with the artificial fast intracellular Ca2+
buffer 1,2 bis-(2-aminophenoxy)ethane-N,N,NV,NV-tetraace-
tic acid (BAPTA). If present in cultured rat hippocampal
neurons, BAPTA augmented rather than diminished gluta-
mate excitotoxicity (Abdel-Hamid and Baimbridge, 1997).
The authors argue that (1) the rapid Ca2+ chelating proper-
ties of BAPTA can provoke a reduction of the Ca2+-
dependent inactivation of voltage-operated Ca2+ channels
and NMDA-mediated Ca2+ channels and (2) BAPTA may
reduce the probability of the activation of Ca2+-dependent
K+ channels, this all leading to an increase of total Ca2+
influx. Along the same line, hippocampal CA1 pyramidal
neurons of CB-deficient knockout (KO) mice demonstrated
less cellular damage following a 12-min carotid artery
occlusion in vivo than the same CB-expressing neuron
population of control animals (Klapstein et al., 1998).
Although the Ca2+-binding kinetic of PV is much slower
than the one of BAPTA, PV was shown to be able to reduce
K+-depolarization-induced elevations of [Ca2+]i in human
neuroblastoma cells (Dreessen et al., 1996), while the
amplitude of brief Ca2+ transients in Purkinje cell dendrites
elicited by climbing fiber stimulation was not affected by
PV (Schmidt et al., 2003). Similar to previous findings in
PV-containing fast-twitch muscles (Schwaller et al., 1999),
an increase in the initial rate of decay of [Ca2+]i after a Ca
2+
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transient in Purkinje cells was attributable to the presence of
PV (Schmidt et al., 2003). The presence of an additional
Ca2+ buffer (PV) will not only directly affect the Ca2+
buffering capacity of the cytosol, but is likely to affect the
dynamics of all systems implicated in regulating [Ca2+]i.
That includes systems involved in Ca2+ entry and extrusion
via the plasma membrane as well as those of intracellular
organelles, such as the endoplasmic reticulum or mitochon-
dria. Thus, the ectopic expression of the slow-onset buffer
PV in all neurons as well as the elimination of PV in
knockout mice could differentially affect the various com-
ponents involved in Ca2+ homeostasis and alter the kinetics
and the quantitative fluxes of Ca2+ ions.
Since more experiments on PV-deficient mice have been
reported so far, the most pertinent findings in PV-KO mice
are summarized here. As described, PV promotes a more
rapid initial decay of [Ca2+]i and hence, the ‘‘residual Ca
2+’’
in a presynaptic terminal after stimulation will be lower
than in the absence of PV. As a result, at the synapse
between PV-containing stellate/basket cells and Purkinje
cells, paired-pulse facilitation was increased in PV-KO mice
(Caillard et al., 2000). Also in the hippocampus, facilitation
of repetitive IPSCs was enhanced in the absence of PV
(Vreugdenhil et al., 2003), both findings can be explained
by the particular slow-onset Ca2+-binding properties of PV.
In addition, the presence of a Ca2+ buffer also affects the
intracellular spreading of Ca2+ ions. Analysis of the mobil-
ity of PV in spines and dendrites of Purkinje cells has
revealed that the range of action for PV-bound Ca2+ was
approximately 4 Am (Schmidt et al., 2003) and thus found
to be very close to the value of 5 Am for ‘‘buffered’’ Ca2+
ions reported before in the cytosol of Xenopus laevis
(Allbritton et al., 1992). This distance is much larger than
the 0.1 Am calculated for a ‘‘free’’ Ca2+ ion in a cytosolic
extract. Thus, due to increased diffusion of Ca2+ bound to
PV, Ca2+ elevations will dissipate faster and spread over
larger distances than in the absence of PV. This dissipation
of PV-buffered Ca2+ will diminish the Ca2+ concentration at
the site of entry, usually just underneath the plasma mem-
brane, and will increase it some distance away in proximity
to intracellular organelles. By this process, Ca2+ extrusion
via plasma membrane systems could be reduced, while
Ca2+ sequestering by organelles is increased. This would
lead to an increased Ca2+ load of these organelles with
serious consequences, at least in mitochondria: at a critical
Ca2+ load, mitochondria depolarize, decrease ATP synthe-
sis, alter the synthesis of mitochondrial polypeptides and
increase the generation of reactive oxygen species, leading
to irreversible mitochondrial dysfunction (Krieger and
Duchen, 2002).
A second factor, ’’remodeling’’, may even further en-
hance mitochondrial dysfunction after an excitotoxic insult:
in neurons ectopically expressing PV, the mitochondrial
fractional area and thus the mitochondrial volume is re-
duced. The electron microscopic analyses revealed a de-
crease in the fractional area of mitochondria by almost 50%,
and the significant decrease of the COXI signal in Western
blots further confirms our morphometric results. Differences
in COXI signal intensities were of smaller magnitude than
changes in fractional area of neuronal mitochondria, as the
whole tissue homogenate used to obtain the protein fraction
contains not only neurons expressing the transgene, but also
glial cells, endothelial cells, etc. It has recently been shown
that in PV-knockout mice, mitochondria in fast-twitch
muscles are up-regulated (Chen et al., 2001), indicating that
in the absence of a diffusible buffer, mitochondria contribute
to Ca2+ buffering. A similar up-regulation also occurs in
Purkinje cells of PV-KO mice, suggesting that a close link
between PV levels and mitochondria volume is not restrict-
ed to muscle cells (B. Schwaller, in preparation). In contrast,
ectopically expressed neuronal PV apparently influences
mitochondrial biogenesis in the opposite direction, that is,
by decreasing the mitochondrial volume, and it is tempting
to speculate that mitochondrial recruitment can be influ-
enced not only by energy metabolism, but also by its
function as a Ca2+ buffer. Since the fractional volume of
mitochondria must be seen in direct correlation to effective-
ness of energy metabolism and capacity of transient Ca2+
storage (Nicholls and Budd, 2000), a higher probability of
excitotoxin-induced neuronal death by reduced mitochon-
drial volume seems plausible.
Additionally, ectopical expression of PV in neurons not
only increased IBO-induced neurodegeneration, but also
affected the microenvironment evidenced by the larger
extent of astrocytic reaction. The area of astrocytic reaction
then diminished from 2 to 4 weeks to a size similar as the
neuron-depleted area. In WT mice also 4 weeks after IBO
injection, the size of astrocytic reaction was still larger than
the neuron-depleted area. One may hypothesize that in Thy-
PV mice, the recovery period after IBO neurotoxicity is
shorter, but mechanisms involved in this accelerated healing
process are currently unknown.
The increased vulnerability of striatal neurons ectopi-
cally expressing PV to glutamate excitotoxicity as opposed
to the neuroprotective effect of PV in motoneurons is an
excellent example that Ca2+ buffers do not have a neuro-
protective effect per se. As more knowledge is gained
about the properties of the Ca2+ buffers themselves, but
equally important about the properties of all systems
involved in the Ca2+ homeostasis in a given cell, we start
to understand why the presence of a Ca2+ buffer may be
neuroprotective under certain conditions but not under
others. If increasing the Ca2+-buffering capacity in selected
neurons may appear useful and eventually also envisaged
as a therapeutic or preventive measure, one has to keep in
mind that ‘‘unwanted’’ remodeling mechanisms might be
induced, which may have just the opposite effect than the
desired one. Thus, only specifically targeted increase in
Ca2+ buffering capacity, both with respect to time scale
and neuron population, may be potentially used as a
strategy to prevent or block certain types of excitotoxic
neurodegeneration.
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